216 related articles for article (PubMed ID: 22232734)
1. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.
Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D
Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734
[TBL] [Abstract][Full Text] [Related]
2. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.
Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D
Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
6. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Virtamo J; Albanes D
Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651
[TBL] [Abstract][Full Text] [Related]
7. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
[TBL] [Abstract][Full Text] [Related]
8. Serum vitamin D, vitamin D binding protein, and lung cancer survival.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
Lung Cancer; 2014 Dec; 86(3):297-303. PubMed ID: 25456734
[TBL] [Abstract][Full Text] [Related]
9. Association of thyroid cancer risk with plasma 25-hydroxyvitamin D and vitamin D binding protein: a case-control study in China.
Hu MJ; Niu QS; Wu HB; Lu XL; Wang L; Tong XR; Huang F
J Endocrinol Invest; 2020 Jun; 43(6):799-808. PubMed ID: 31863361
[TBL] [Abstract][Full Text] [Related]
10. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
12. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
13. Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.
Wang J; Eliassen AH; Spiegelman D; Willett WC; Hankinson SE
Cancer Causes Control; 2014 Jul; 25(7):819-27. PubMed ID: 24748579
[TBL] [Abstract][Full Text] [Related]
14. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
[TBL] [Abstract][Full Text] [Related]
16. Free vitamin D
Grut V; Biström M; Salzer J; Stridh P; Lindam A; Alonso-Magdalena L; Andersen O; Jons D; Gunnarsson M; Vrethem M; Hultdin J; Sundström P
Eur J Neurol; 2022 Aug; 29(8):2335-2342. PubMed ID: 35582958
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
18. In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations.
Dastani Z; Berger C; Langsetmo L; Fu L; Wong BY; Malik S; Goltzman D; Cole DE; Richards JB
J Bone Miner Res; 2014 Feb; 29(2):494-9. PubMed ID: 23857798
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952
[TBL] [Abstract][Full Text] [Related]
20. Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
Jemielita TO; Leonard MB; Baker J; Sayed S; Zemel BS; Shults J; Herskovitz R; Denburg MR
Osteoporos Int; 2016 Feb; 27(2):617-26. PubMed ID: 26359185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
